Skip to main content
. Author manuscript; available in PMC: 2016 Jun 2.
Published in final edited form as: J Thorac Imaging. 2015 Mar;30(2):79–87. doi: 10.1097/RTI.0000000000000136

TABLE 7.

Incremental Cost-effectiveness (Base Case)

Strategy Cost LE QALE Incremental Costs* Incremental Lys Incremental QALYs $/LY 95% CI $/QALY 95% CI
CT $3074 14.7386 10.9692 $1631 0.0316 0.0201 52,000 34,000–106,000 81,000 52,000–186,000
Radiography $1911 14.7071 10.9491 $469 0 0 Dom Dom
None† $1443 14.7071 10.9491 — — — — —

Reprinted with permission from Black et al.6

*

Incremental costs are in reference to the None strategy because the Radiography strategy is dominated.

†

Cost in the None strategy includes diagnosis and treatment of lung cancer without LDCT or radiographic screening.

Dom indicates dominated.